As FOXP3 is the most widely accepted single immunohistochemical marker for Treg and has been shown to have some prognostic value, we confirmed that FOXP3 accumulated in the nuclei of small, round mononuclear lymphocytes that were clearly distinct from tumor cells [10]–[13]. Here, FOXP3 is linked to neoplasm.